Free shipping on all orders over $ 500

PE859

Cat. No. M5296

All AbMole products are for research use only, cannot be used for human consumption.

PE859 Structure
Synonym:

PE-859; PE 859

Size Price Availability Quantity
5mg USD 310  USD310 In stock
10mg USD 460  USD460 In stock
50mg USD 1280  USD1280 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

In vitro: PE859 inhibits the heparin-induced aggregation of both 3RMBD and full length tau in a concentration-dependent manner. In each assay, the IC50 values calculated at the last measurement periods are 0.81 μM, and 2.23 μM, respectively. PE859 inhibits tau aggregation through formation of beta-sheet structure. In vivo: PE859 could cross the blood-brain barrier and that PE859 could be distributed into the tissues of the central nervous system. The maximum concentration of PE859 is 2.005 μg/mL in the blood at 3 h and 1.428 μg/g in the brain at 6 h. PE859 delays onset and progression of the motor dysfunction in JNPL3 mice. PE859 delays progression of the motor dysfunction through the inhibition of accumulation of sarkosyl-insoluble tau.

Protocol (for reference only)
Cell Experiment
Cell lines
Preparation method
Concentrations
Incubation time
Animal Experiment
Animal models ICR mice
Formulation 80% PEG 400, 10% HCO40 and 10% water solution
Dosages 40 mg/kg
Administration i.p.
Chemical Information
Molecular Weight 448.52
Formula C28H24N4O2
CAS Number 1402727-29-0
Form Solid
Solubility (25°C) 10mM in DMSO
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Okuda M, et al. Bioorg Med Chem Lett. Design and synthesis of curcumin derivatives as tau and amyloid β dual aggregation inhibitors.

[2] Okuda M, et al. PLoS One. PE859, a novel tau aggregation inhibitor, reduces aggregated tau and prevents onset and progression of neural dysfunction in vivo.

Related Microtubule Products
CCB02

CCB02 is a selective CPAP-tubulin interaction inhibitor, binding to tubulin and competing for the CPAP binding site of β-tubulin, with an IC50 of 689 nM, and shows potent anti-tumor activity.

Lisavanbulin

Lisavanbulin (BAL-101553) is the prodrug of the microtubule targeting agent Avanbulin (BAL 27862).

20-O-Demethyl-AP3 

20-O-Demethyl-AP3 is a minor metabolite of Ansamitocin P-3.

Lisavanbulin dihydrochloride

Lisavanbulin (BAL-101553) dihydrochloride is the prodrug of the microtubule targeting agent Avanbulin (BAL 27862).

Paclitaxel-d5

Paclitaxel-d5

  Catalog
Abmole Inhibitor Catalog




Keywords: PE859, PE-859; PE 859 supplier, Microtubule, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.